Showing Results for
- Academic Journals (1,181)
Search Results
- 1,181
Academic Journals
- 1,181
- 1From:Dermatology News (Vol. 52, Issue 2)Evidence that a SARS-CoV-2 vaccine is associated with inflammatory reactions in patients with dermal fillers has led the American Society for Dermatologic Surgery to issue a guidance outlining the potential risk and...
- 2From:Journal of Family Practice (Vol. 70, Issue 2) Peer-ReviewedPrioritized immunization is advised with the 2 COVID-19 vaccines. A third meningococcal ACWY vaccine is now the only one approved for those > 55 years. The year 2020 was challenging for public health agencies and...
- 3From:Nature Reviews Drug Discovery (Vol. 20, Issue 1) Peer-ReviewedAuthor(s): Asher Mullard Author Affiliations: COVID-19 vaccines buoy hope Barely a year since the emergence of the SARS-CoV-2 virus, multiple vaccine developers are poised to secure emergency authorization in...
- 4From:SAMJ South African Medical Journal (Vol. 111, Issue 5) Peer-ReviewedThe Democratic Republic of the Congo (DRC) declared the end of its 10th Ebola virus disease (EVD) outbreak on 25 June 2020. The outbreak was declared in North Kivu on 1 August 2018, and by the time it ended there had...
- 5From:Nature (Vol. 591, Issue 7851) Peer-ReviewedEven with vaccination efforts in full force, the theoretical threshold for vanquishing COVID-19 looks to be out of reach. Even with vaccination efforts in full force, the theoretical threshold for vanquishing COVID-19...
- 6From:Archives of Pediatric Neurosurgery (Vol. 3, Issue 1) Peer-ReviewedOn 11 March, the WHO confirmed coronavirus disease 2019 as a pandemic. The Director-General of the WHO called on governments to change its course by taking "urgent and aggressive action" (1). In terms of the number of...
- 7From:Nature (Vol. 590, Issue 7845) Peer-ReviewedThe country is the first to see a direct effect of vaccines working in such a large group of people. The country is the first to see a direct effect of vaccines working in such a large group of people. Author(s):...
- 8From:Clinical Psychiatry News (Vol. 49, Issue 5)Welcome to our national obsession: Vaccines! You may have noticed--it's all talk, all the time, with short breaks to discuss what we're watching on Netflix. For months, every session with almost every patient includes...
- 9From:Saudi Medical Journal (Vol. 42, Issue 2) Peer-Reviewed16 January 2021--More than 2,800 scientists from 130 countries gathered on Friday (January 15) in a virtual forum hosted by the World Health Organization (WHO) to identify knowledge gaps and set research priorities for...
- 10From:Nature (Vol. 586, Issue 7830) Peer-ReviewedA safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic.sup.1-8. For global deployment and pandemic control, a...
- 11From:Saudi Medical Journal (Vol. 42, Issue 3) Peer-Reviewed16 February 2021 Joint News Release Geneva / New York / Oslo--The Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance (Gavi) and the World Health Organization (WHO), as co-leads of the...
- 12From:SAMJ South African Medical Journal (Vol. 111, Issue 3) Peer-Reviewed2020 changed our lives. For too many it was the end of their life. For all of us, it heralded a new reality. During 2020 my social media feed was full of people wishing the year would end. I thought that little would...
- 13From:Biomedical and Biotechnology Research Journal (Vol. 5, Issue 4) Peer-ReviewedByline: Pramita. Sharma, Himel. Mondal, Shaikat. Mondal, Rabindranath. Majumder The pandemic of novel coronavirus disease-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has stimulated...
- 14From:PLoS ONE (Vol. 16, Issue 12) Peer-ReviewedIntroduction COVID-19 poses significant health and economic threat prompting international firms to rapidly develop vaccines and secure quick regulatory approval. Although COVID-19 vaccination priority is given for...
- 15From:Pharmaceutical Technology (Issue S1) Peer-ReviewedThe Editors of Pharmaceutical Technology A key driver of the massive effort to manufacturer and deliver COVID-19 vaccines in record time has been the development and production support provided by contract...
- 16From:Journal of Clinical and Scientific Research (Vol. 11, Issue 1) Peer-ReviewedByline: G. Rao, R. Ram, B. Vengamma Background: Concern about vaccine hesitancy is growing worldwide. Vaccine hesitancy can have effects for both the individual and the community, especially in the context of severe...
- 17From:Emerging Infectious Diseases (Vol. 28, Issue 2) Peer-ReviewedPopulation-based data on coronavirus disease in Russia and on the immunogenicity of the Sputnik V vaccine are sparse. In a survey of 1,080 residents of Arkhangelsk 40-75 years of age, 65% were seropositive for IgG....
- 18From:PLoS ONE (Vol. 17, Issue 3) Peer-ReviewedTo promote COVID-19 vaccination, many states in the US introduced financial incentives ranging from small, guaranteed rewards to lotteries that give vaccinated individuals a chance to win large prizes. There is limited...
- 19From:Emerging Infectious Diseases (Vol. 27, Issue 11) Peer-ReviewedIn Israel, the BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 was approved for use in adolescents in June 2021, shortly before an outbreak of B.1.617.2 (Delta) variant-dominant infection. We...
- 20From:Oncology Nurse AdvisorCancer patients have been underrepresented in clinical trials of COVID-19 vaccines, so it hasn?t been clear how well the vaccines protect these patients.1 However, researchers have conducted several studies...